Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
German Clinical Trials Register |
Last refreshed on:
|
8 April 2024 |
Main ID: |
DRKS00008015 |
Date of registration:
|
16/04/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Effect of Exercise training of different intensities on headache symptoms, physical fitness, cerebral capacity, endocrine function and pain perception in migraineurs
|
Scientific title:
|
Effect of Exercise training of different intensities on headache symptoms, physical fitness, cerebral capacity, endocrine function and pain perception in migraineurs - MIGSPO |
Date of first enrolment:
|
21/03/2014 |
Target sample size:
|
38 |
Recruitment status: |
Recruiting |
URL:
|
http://drks.de/search/en/trial/DRKS00008015 |
Study type:
|
interventional |
Study design:
|
Allocation: Randomized controlled study; Masking: Open (masking not used); Control: active; Assignment: parallel; Study design purpose: treatment
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Switzerland
| | | | | | | |
Contacts
|
Name:
|
Lars
Donath |
Address:
|
Birsstrasse 320 B
4052
Basel
Switzerland |
Telephone:
|
+ 41 (0)61 377 87 38 |
Email:
|
lars.donath@unibas.ch |
Affiliation:
|
Departement für Sport, Bewegung und GesundheitUniversität Basel |
|
Name:
|
Gavin
Brupbacher |
Address:
|
Birsstrasse 320 B
4052
Basel
Switzerland |
Telephone:
|
+41 (0)61 377 87 51 |
Email:
|
gavin.brupbacher@unibas.ch |
Affiliation:
|
Departement für Sport, Bewegung und GesundheitUniversität Basel |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Diagnosis of migraine by an experienced neurologist according to the International Classification of Headache Disorders, second edition (ICHD-II).
Exclusion criteria: (a) current medical preventive therapy (patients can be included if preventive medication was stopped at least 8 weeks before study entry), (b) other internal or neurological diseases, (c) regular exercise experiences (>2h of moderate to vigorous exercise per week) within the last 6 months, (d) patients with coronary heart disease, (e) chronic heart failure, (f) hypertension, (g) current use of antihypertensive medication or (h) peripheral arterial disease.
Age minimum:
18 Years
Age maximum:
50 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
G43.0
|
G43.1
|
Migraine without aura [common migraine]
|
G43.0 G43.1
|
Migraine with aura [classical migraine]
|
Intervention(s)
|
Group 1: High-intensity interval training: running training 2x/week for 12 weeks, with 4x4 minute intervals at 90% maximum heart rate with 3 minutes active recovery in between intervals at 70% maximum heart rate. The high-intensity interval training and the continuous training are isocaloric. Group 2: Continuous aerobic training: running training 2/week for 12 weeks for 45 minutes at 70% maximum heart rate. The high-intensity interval training and the continuous training are isocaloric. Group 3: Control group, i.e. no training intervention but other behaviour and medication as usual
|
Primary Outcome(s)
|
The number of days with headache will be measured using a headache diary during run-in, intervention and follow up.
|
Secondary Outcome(s)
|
Headache intensity and number of days with migraine is measured during run-in, intervention and follow up using a diary. Headache associated disability (MIDAS questionnaire), cerebral (fMRI), endocrine (serum B-Endorphin), kognitive (Mini-Mental-State test, Trail Making Test, SWITCH Test, Tower of London Test, Regensburger Wortflüssigkeitstest, Frontal Assessment Batttery), and vascular function (retinal vessel diameter, SVA-T), cardio-respiratory fitness (spiroergometry), pain thresholds (thermode), and quality of life (WHO-QoL, BREF) are measured before and after the intervention phase.
|
Source(s) of Monetary Support
|
Universität Basel Vizerektorat Forschung Petersgraben 35, Postfach
|
Ethics review
|
Status: Approved
Approval date: 13/08/2013
Contact:
Ethikkommission Nordwest- und Zentralschweiz (EKNZ) [Ethikkommission Nordwest- und Zentralschweiz]
|
|